中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
17期
8-10
,共3页
脑出血%中西医结合疗法%疗效
腦齣血%中西醫結閤療法%療效
뇌출혈%중서의결합요법%료효
Cerebral hemorrhage%Integrative medicine therapy%Effect
目的：研究中西医结合疗法在治疗脑出血的临床疗效。方法：将符合筛选条件的128例患者随机分为治疗组与对照组。对照组采用常规西医治疗，治疗组在对照组基础上加用疏血通。治疗14d后评价两组患者治疗疗效。结果：经过14d治疗，治疗组显效率为80.95%，明显高于对照组（30.77%）（P<0.01）。治疗组NIHSS评分为（3.58±3.01），明显低于对照组（7.62±3.60）（P<0.01）；治疗组Fugl-meyer评分为（40.1±17.3），明显高于对照组（19.9±14.0）（P<0.01）；治疗组Barthel评分为（59.2±14.2），明显高于对照组（40.7±10.5）（P<0.01)。结论：对于高血压性脑出血患者，采用疏血通结合西医治疗疗效确切，可降低因脑出血导致患者残疾。
目的：研究中西醫結閤療法在治療腦齣血的臨床療效。方法：將符閤篩選條件的128例患者隨機分為治療組與對照組。對照組採用常規西醫治療，治療組在對照組基礎上加用疏血通。治療14d後評價兩組患者治療療效。結果：經過14d治療，治療組顯效率為80.95%，明顯高于對照組（30.77%）（P<0.01）。治療組NIHSS評分為（3.58±3.01），明顯低于對照組（7.62±3.60）（P<0.01）；治療組Fugl-meyer評分為（40.1±17.3），明顯高于對照組（19.9±14.0）（P<0.01）；治療組Barthel評分為（59.2±14.2），明顯高于對照組（40.7±10.5）（P<0.01)。結論：對于高血壓性腦齣血患者，採用疏血通結閤西醫治療療效確切，可降低因腦齣血導緻患者殘疾。
목적：연구중서의결합요법재치료뇌출혈적림상료효。방법：장부합사선조건적128례환자수궤분위치료조여대조조。대조조채용상규서의치료，치료조재대조조기출상가용소혈통。치료14d후평개량조환자치료료효。결과：경과14d치료，치료조현효솔위80.95%，명현고우대조조（30.77%）（P<0.01）。치료조NIHSS평분위（3.58±3.01），명현저우대조조（7.62±3.60）（P<0.01）；치료조Fugl-meyer평분위（40.1±17.3），명현고우대조조（19.9±14.0）（P<0.01）；치료조Barthel평분위（59.2±14.2），명현고우대조조（40.7±10.5）（P<0.01)。결론：대우고혈압성뇌출혈환자，채용소혈통결합서의치료료효학절，가강저인뇌출혈도치환자잔질。
Objective:To explore the effect of the integrative medicine therapy in the treatment of cerebral hemorrhage. Methods:128 cases were randomly divided into the treated group and control group. The control group were taken normal modern medicine treatment, while the treated group was given the Shuxuetong injection more. Compared the efficiency of the 2 groups after 14ds’ treatment. Results: After 14ds’ treatment, the significant efficiency in the treated group was 80.95%, which was obviously higher than that in the control group 30.77%(P<0.01);The NIHSS score in the treated group was (3.58±3.01), which was lower than the score (7.62±3.60) of the control group (P<0.01);The treated group was more than the control group in the Fugl-meyer’s score, which respectively were (40.1± 17.3) and (19.9±14.0);The Barthel’s score in the treated group was (59.2±14.2), which was more than the (40.7±10.5) of the control group (P<0.01). Conclusion: Combining the Shuxuetong injection with the modern medicine treatment has a better curractive effect in treating hypertensive intracerebral hemorrhage. It can reduce the disability rate of the cerebral hemorrhage patients.
